HUP0303589A2 - Egy taxán és egy ciklin-dependens kináz inhibitor kombinációja - Google Patents
Egy taxán és egy ciklin-dependens kináz inhibitor kombinációjaInfo
- Publication number
- HUP0303589A2 HUP0303589A2 HU0303589A HUP0303589A HUP0303589A2 HU P0303589 A2 HUP0303589 A2 HU P0303589A2 HU 0303589 A HU0303589 A HU 0303589A HU P0303589 A HUP0303589 A HU P0303589A HU P0303589 A2 HUP0303589 A2 HU P0303589A2
- Authority
- HU
- Hungary
- Prior art keywords
- cyclin
- kinase inhibitor
- dependent kinase
- component
- taxane
- Prior art date
Links
- 229940126074 CDK kinase inhibitor Drugs 0.000 title abstract 2
- 102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 title abstract 2
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 title abstract 2
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 title abstract 2
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 title abstract 2
- 229940123237 Taxane Drugs 0.000 title 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 2
- 229930012538 Paclitaxel Natural products 0.000 abstract 2
- BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical group O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 abstract 2
- 229950010817 alvocidib Drugs 0.000 abstract 2
- 229960001592 paclitaxel Drugs 0.000 abstract 2
- 125000002456 taxol group Chemical group 0.000 abstract 2
- 229940063683 taxotere Drugs 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgyát legalább két összetevőt tartalmazógyógyszerkészítmény képezi, amelyben az egyik összetevő a Taxol<,Taxotere< vagy ezek származékai és a másik összetevő egy ciklin-dependens kináz inhibitor. A találmány további tárgyát képezi továbbáegy olyan gyógyszerkészítmény a daganatos betegségek kezelésére,amelyben az egyik összetevő a Taxol<, Taxotere< vagy ezek származékaiés a másik összetevő a flavopiridol, és ahol az összetevőkelkülönítetten és időközökben kerülnek beadásra, a flavopiridol pedigorálisan kerül beadásra. Ó
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27794801P | 2001-03-23 | 2001-03-23 | |
| US30269201P | 2001-07-05 | 2001-07-05 | |
| US33491601P | 2001-12-04 | 2001-12-04 | |
| PCT/EP2002/004083 WO2002076484A2 (en) | 2001-03-23 | 2002-03-22 | Combination of a taxane and a cyclin-dependent kinase inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0303589A2 true HUP0303589A2 (hu) | 2004-03-01 |
| HUP0303589A3 HUP0303589A3 (en) | 2007-05-02 |
| HU229258B1 HU229258B1 (en) | 2013-10-28 |
Family
ID=27402954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303589A HU229258B1 (en) | 2001-03-23 | 2002-03-22 | Combination of a taxane and a cyclin-dependent kinase inhibitor |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20020182204A1 (hu) |
| EP (1) | EP1372652B1 (hu) |
| JP (1) | JP2004521140A (hu) |
| KR (1) | KR100879712B1 (hu) |
| CN (1) | CN1498107A (hu) |
| AR (1) | AR034222A1 (hu) |
| AT (1) | ATE395917T1 (hu) |
| AU (1) | AU2002312815B2 (hu) |
| BR (1) | BR0208221A (hu) |
| CA (1) | CA2441441C (hu) |
| CY (1) | CY1110449T1 (hu) |
| CZ (1) | CZ301423B6 (hu) |
| DE (1) | DE60226710D1 (hu) |
| DK (1) | DK1372652T3 (hu) |
| EA (1) | EA007815B1 (hu) |
| ES (1) | ES2305253T3 (hu) |
| HR (1) | HRPK20030766B3 (hu) |
| HU (1) | HU229258B1 (hu) |
| IL (2) | IL158058A0 (hu) |
| ME (1) | MEP16408A (hu) |
| MX (1) | MXPA03007743A (hu) |
| NO (1) | NO332441B1 (hu) |
| NZ (1) | NZ527655A (hu) |
| PE (1) | PE20020907A1 (hu) |
| PL (1) | PL206118B1 (hu) |
| PT (1) | PT1372652E (hu) |
| RS (1) | RS50681B (hu) |
| SI (1) | SI1372652T1 (hu) |
| SK (1) | SK287481B6 (hu) |
| TW (1) | TWI355935B (hu) |
| UY (1) | UY27220A1 (hu) |
| WO (1) | WO2002076484A2 (hu) |
| ZA (1) | ZA200307381B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487434B1 (en) * | 2002-03-06 | 2007-05-09 | The Medical Research and Education Trust | Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| AU2003287081A1 (en) * | 2002-10-16 | 2004-05-04 | Ilex Products, Inc. | Clofarabine and taxane chemotherapy combination |
| ES2318202T3 (es) * | 2002-11-06 | 2009-05-01 | Cyclacel Limited | Combinacion que comprende docetaxel y un inhibidor de cdk. |
| JP5537035B2 (ja) * | 2006-02-10 | 2014-07-02 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | Ｃｄｋ阻害剤、および成長因子抗体または抗有糸分裂剤を含む組合せ |
| CN104220066A (zh) * | 2010-11-19 | 2014-12-17 | 皮拉马尔企业有限公司 | 紫杉醇和cdk抑制剂药物组合物 |
| PL2694056T3 (pl) * | 2011-04-01 | 2020-03-31 | Astrazeneca Ab | Leczenie terapeutyczne |
| MY175800A (en) | 2011-11-30 | 2020-07-09 | Astrazeneca Ab | Combination treatment of cancer |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| AU2195297A (en) * | 1996-02-20 | 1997-09-02 | Sloan-Kettering Institute For Cancer Research | Combinations of pkc inhibitors and therapeutic agents for treating cancers |
-
2002
- 2002-03-21 UY UY27220A patent/UY27220A1/es not_active Application Discontinuation
- 2002-03-21 US US10/101,947 patent/US20020182204A1/en not_active Abandoned
- 2002-03-22 AU AU2002312815A patent/AU2002312815B2/en not_active Ceased
- 2002-03-22 ME MEP-164/08A patent/MEP16408A/xx unknown
- 2002-03-22 CA CA002441441A patent/CA2441441C/en not_active Expired - Fee Related
- 2002-03-22 JP JP2002574997A patent/JP2004521140A/ja active Pending
- 2002-03-22 IL IL15805802A patent/IL158058A0/xx unknown
- 2002-03-22 EA EA200301053A patent/EA007815B1/ru not_active IP Right Cessation
- 2002-03-22 BR BR0208221-7A patent/BR0208221A/pt not_active Application Discontinuation
- 2002-03-22 NZ NZ527655A patent/NZ527655A/xx not_active IP Right Cessation
- 2002-03-22 AR ARP020101061A patent/AR034222A1/es unknown
- 2002-03-22 DK DK02737950T patent/DK1372652T3/da active
- 2002-03-22 PT PT02737950T patent/PT1372652E/pt unknown
- 2002-03-22 SI SI200230711T patent/SI1372652T1/sl unknown
- 2002-03-22 PL PL367702A patent/PL206118B1/pl not_active IP Right Cessation
- 2002-03-22 DE DE60226710T patent/DE60226710D1/de not_active Expired - Lifetime
- 2002-03-22 PE PE2002000230A patent/PE20020907A1/es not_active Application Discontinuation
- 2002-03-22 MX MXPA03007743A patent/MXPA03007743A/es active IP Right Grant
- 2002-03-22 AT AT02737950T patent/ATE395917T1/de active
- 2002-03-22 ES ES02737950T patent/ES2305253T3/es not_active Expired - Lifetime
- 2002-03-22 TW TW091105567A patent/TWI355935B/zh not_active IP Right Cessation
- 2002-03-22 CN CNA028070380A patent/CN1498107A/zh active Pending
- 2002-03-22 KR KR1020037012338A patent/KR100879712B1/ko not_active IP Right Cessation
- 2002-03-22 WO PCT/EP2002/004083 patent/WO2002076484A2/en active IP Right Grant
- 2002-03-22 EP EP02737950A patent/EP1372652B1/en not_active Expired - Lifetime
- 2002-03-22 SK SK1169-2003A patent/SK287481B6/sk not_active IP Right Cessation
- 2002-03-22 CZ CZ20032551A patent/CZ301423B6/cs not_active IP Right Cessation
- 2002-03-22 RS YUP-695/03A patent/RS50681B/sr unknown
- 2002-03-22 HU HU0303589A patent/HU229258B1/hu not_active IP Right Cessation
-
2003
- 2003-09-16 NO NO20034124A patent/NO332441B1/no not_active IP Right Cessation
- 2003-09-22 IL IL158058A patent/IL158058A/en not_active IP Right Cessation
- 2003-09-22 HR HR20030766A patent/HRPK20030766B3/xx not_active IP Right Cessation
- 2003-09-22 ZA ZA2003/07381A patent/ZA200307381B/en unknown
-
2006
- 2006-01-27 US US11/341,840 patent/US20060128640A1/en not_active Abandoned
-
2008
- 2008-08-11 CY CY20081100843T patent/CY1110449T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2015003I2 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| EE200300440A (et) | Epotilooni analoogide ja kemoterapeutikumide kombinatsioon proliferatiivsete haiguste raviks | |
| NO20052312L (no) | Kombinasjonsprodukt av inhibitor fra SRC-familien av ikke-reseptor-tyrosinkinaser og gemcitabin. | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| CY1105349T1 (el) | Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec | |
| SE0301700D0 (sv) | Novel compounds | |
| CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
| DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
| RS20080167A (en) | Novel improved compositions for cancer therapy | |
| CY1105225T1 (el) | Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας | |
| IS2855B (is) | 4-anilínókínasólínafleiður sem andfjölgunarefni | |
| ATE353888T1 (de) | Chinazolinderivate | |
| RS20050070A (en) | Use of 1kb kinase inhibitors for the treatment of pain | |
| CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
| MXPA05009885A (es) | Nuevas triazolonas fusionadas y los usos de las mismas. | |
| HUP0300848A2 (hu) | Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére | |
| IL161744A (en) | Use of zd6474 and taxane in the manufacture of a medicament for the treatment of cancer and pharmaceutical compositions and kits comprising such compounds | |
| TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
| CY1110449T1 (el) | Συνδυασμος δοκεταξελης και φλαβοπιριδinολης | |
| BRPI0411864A (pt) | combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
| EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
| PT1268472E (pt) | Inibidores 3-aminopirazolicos de cinases dependentes da ciclina | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| CY1116137T1 (el) | Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |